Reduced dorsal prefrontal gray matter after chronic ketamine use

Biological Psychiatry

Volumn 69, Issue 1, 2011, Pages 42-48

  Liao, Yanhui ^a   Tang, Jinsong ^a   Corlett, Philip R ^d   Wang, Xuyi ^a   Yang, Mei ^b   Chen, Hongxian ^a   Liu, Tieqiao ^a   Chen, Xiaogang ^a   Hao, Wei ^a   Fletcher, Paul C ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Brain Hospital   (China)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Frontal cortex; Gray matter volume; Ketamine; Structural MRI; Voxel based morphometry

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; CAFFEINE; CANNABIS; COCAINE; DIAMORPHINE; DIAZEPAM; KETAMINE; METHAMPHETAMINE;

ADULT; ARTICLE; BLADDER DYSFUNCTION; BRAIN FUNCTION; BRAIN MAPPING; BRAIN REGION; BRAIN SIZE; CHRONIC GASTRITIS; CHRONIC HEPATITIS; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG USE; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; GRAY MATTER; HEPATITIS B; HUMAN; IMAGE PROCESSING; MALE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY;

ADULT; ANESTHETICS, DISSOCIATIVE; ATROPHY; BRAIN MAPPING; FEMALE; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, UNMYELINATED; PREFRONTAL CORTEX; SUBSTANCE-RELATED DISORDERS;

EID: 78649997344     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.08.030     Document Type: Article

References (63)

1. K.S. Leung, J.H. Li, W.I. Tsay, C. Callahan, S.F. Liu, and J. Hsu Dinosaur girls, candy girls, and Trinity: Voices of Taiwanese club drug users J Ethn Subst Abus 7 2008 237 257
2. K. Joe-Laidler, and G. Hunt Sit Down to float: The cultural meaning of ketamine use in Hong Kong Addict Res Theory 16 2008 259 271
3. Y.X. Fang, Y.B. Wang, J. Shi, Z.M. Liu, and L. Lu Recent trends in drug abuse in China Acta Pharmacol Sin 27 2006 140 144
4. A.C. Lua, H.R. Lin, Y.T. Tseng, A.R. Hu, and P.C. Yeh Profiles of urine samples from participants at rave party in Taiwan: Prevalence of ketamine and MDMA abuse Forensic Sci Int 136 2003 47 51
5. J. McCambridge, A. Winstock, N. Hunt, and L. Mitcheson 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users Eur Addict Res 13 2007 57 64
6. L. Degenhardt, and M. Dunn The epidemiology of GHB and ketamine use in an Australian household survey Int J Drug Policy 19 2008 311 316
7. C.J. Morgan, L. Muetzelfeldt, and H.V. Curran Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: A 1-year longitudinal study Addiction 105 2010 121 133
8. T.H. Tsai, T.L. Cha, C.M. Lin, C.W. Tsao, S.H. Tang, and F.P. Chuang Ketamine-associated bladder dysfunction Int J Urol 16 2009 826 829
9. P.S. Chu, S.C. Kwok, K.M. Lam, T.Y. Chu, S.W. Chan, and C.W. Man 'Street ketamine'-associated bladder dysfunction: A report of ten cases Hong Kong Med J 13 2007 311 313
10. J.R. Gill, and M. Stajic Ketamine in non-hospital and hospital deaths in New York City J Forensic Sci 45 2000 655 658
11. F. Schifano, J. Corkery, A. Oyefeso, T. Tonia, and A.H. Ghodse Trapped in the "K-hole": Overview of deaths associated with ketamine misuse in the UK (19932006) J Clin Psychopharmacol 28 2008 114 116
12. H.H. Holcomb, A.C. Lahti, D.R. Medoff, M. Weiler, and C.A. Tamminga Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically Neuropsychopharmacology 25 2001 165 172
13. A. Breier, A.K. Malhotra, D.A. Pinals, N.I. Weisenfeld, and D. Pickar Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers Am J Psychiatry 154 1997 805 811
14. J.F. Deakin, J. Lees, S. McKie, J.E. Hallak, S.R. Williams, and S.M. Dursun Glutamate and the neural basis of the subjective effects of ketamine: A pharmaco-magnetic resonance imaging study Arch Gen Psychiatry 65 2008 154 164
15. R.A. Honey, G.D. Honey, C. O'Loughlin, S.R. Sharar, D. Kumaran, and E.T. Bullmore Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: An FMRI study Neuropsychopharmacology 29 2004 1203 1214
16. G.D. Honey, R.A. Honey, C. O'Loughlin, S.R. Sharar, D. Kumaran, and J. Suckling Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: An fMRI study Cereb Cortex 15 2005 749 759
17. P.R. Corlett, G.D. Honey, M.R. Aitken, A. Dickinson, D.R. Shanks, and A.R. Absalom Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: Linking cognition, brain activity, and psychosis Arch Gen Psychiatry 63 2006 611 621
18. G.R. Ridgway, S.M. Henley, J.D. Rohrer, R.I. Scahill, J.D. Warren, and N.C. Fox Ten simple rules for reporting voxel-based morphometry studies Neuroimage 40 2008 1429 1435
19. N.R. Giuliani, V.D. Calhoun, G.D. Pearlson, A. Francis, and R.W. Buchanan Voxel-based morphometry versus region of interest: A comparison of two methods for analyzing gray matter differences in schizophrenia Schizophr Res 74 2005 135 147
20. Y. Liao, J. Tang, M. Ma, Z. Wu, M. Yang, and X. Wang Frontal white matter abnormalities following chronic ketamine use: A diffusion tensor imaging study Brain 133 2010 2115 2122
21. R.L. Spitzer, J.B. Williams, M. Gibbon, and M.B. First The Structured Clinical Interview for DSM-III-R (SCID) I: History, rationale, and description Arch Gen Psychiatry 49 1992 624 629
22. J. Ashburner, and K.J. Friston Unified segmentation Neuroimage 26 2005 839 851
23. M.B. Cuadra, L. Cammoun, T. Butz, O. Cuisenaire, and J.P. Thiran Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images IEEE Trans Med Imaging 24 2005 1548 1565
24. C.R. Genovese, N.A. Lazar, and T. Nichols Thresholding of statistical maps in functional neuroimaging using the false discovery rate Neuroimage 15 2002 870 878
25. S. Hayasaka, K.L. Phan, I. Liberzon, K.J. Worsley, and T.E. Nichols Nonstationary cluster-size inference with random field and permutation methods Neuroimage 22 2004 676 687
26. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 1997 2921 2927
27. A. Anand, D.S. Charney, D.A. Oren, R.M. Berman, X.S. Hu, A. Cappiello, and J.H. Krystal Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists Arch Gen Psychiatry 57 2000 270 276
28. J.W. Olney Neurotoxicity of NMDA receptor antagonists: An overview Psychopharmacol Bull 30 1994 533 540
29. F.R. Sharp, M. Tomitaka, M. Bernaudin, and S. Tomitaka Psychosis: Pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci 24 2001 330 334
30. Y.T. Mak, W.P. Lam, L. Lu, Y.W. Wong, and D.T. Yew The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron Microsc Res Tech 73 2010 195 201
31. D.Y. Zuo, Y.L. Wu, W.X. Yao, Y. Cao, C.F. Wu, and M. Tanaka Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis Pharmacol Biochem Behav 86 2007 1 7
32. P.C. Fletcher, and G.D. Honey Schizophrenia, ketamine and cannabis: Evidence of overlapping memory deficits Trends Cogn Sci 10 2006 167 174
33. C.J. Morgan, and H.V. Curran Acute and chronic effects of ketamine upon human memory: A review Psychopharmacology 188 2006 408 424
34. F.X. Vollenweider, K.L. Leenders, C. Scharfetter, A. Antonini, P. Maguire, J. Missimer, and J. Angst Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) Eur Neuropsychopharmacol 7 1997 9 24 (Pubitemid 27139716)
35. L.M. Rowland, L. Beason-Held, C.A. Tamminga, and H.H. Holcomb The interactive effects of ketamine and nicotine on human cerebral blood flow Psychopharmacology 208 2010 575 584
36. G.D. Honey, P.R. Corlett, A.R. Absalom, M. Lee, E. Pomarol-Clotet, and G.K. Murray Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo J Neurosci 28 2008 6295 6303
37. R. Narendran, W.G. Frankle, R. Keefe, R. Gil, D. Martinez, and M. Slifstein Altered prefrontal dopaminergic function in chronic recreational ketamine users Am J Psychiatry 162 2005 2352 2359
38. J.H. Krystal, E.B. Perry Jr, R. Gueorguieva, A. Belger, S.H. Madonick, and A. Abi-Dargham Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: Implications for glutamatergic and dopaminergic model psychoses and cognitive function Arch Gen Psychiatry 62 2005 985 994
39. F.X. Vollenweider, and M.A. Geyer A systems model of altered consciousness: Integrating natural and drug-induced psychoses Brain Res Bull 56 2001 495 507
40. I. Ellison-Wright, and E. Bullmore Anatomy of bipolar disorder and schizophrenia: A meta-analysis Schizophr Res 117 2010 1 12
41. R. Smieskova, P. Fusar-Poli, P. Allen, K. Bendfeldt, R.D. Stieglitz, and J. Drewe Neuroimaging predictors of transition to psychosisa systematic review and meta-analysis Neurosci Biobehav Rev 34 2010 1207 1222
42. E. Pomarol-Clotet, G.D. Honey, G.K. Murray, P.R. Corlett, A.R. Absalom, and M. Lee Psychological effects of ketamine in healthy volunteers Phenomenological study Br J Psychiatry 189 2006 173 179
43. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, and J.D. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
44. S. Paradiso, E. Chemerinski, K.M. Yazici, A. Tartaro, and R.G. Robinson Frontal lobe syndrome reassessed: Comparison of patients with lateral or medial frontal brain damage J Neurol Neurosurg Psychiatry 67 1999 664 667
45. T.E. Feinberg, and J.P. Keenan Where in the brain is the self? Conscious Cogn 14 2005 661 678
46. P.R. Corlett, G.K. Murray, G.D. Honey, M.R. Aitken, D.R. Shanks, and T.W. Robbins Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions Brain 130 2007 2387 2400
47. H. Liu, Y. Hao, Y. Kaneko, X. Ouyang, Y. Zhang, and L. Xu Frontal and cingulate gray matter volume reduction in heroin dependence: Optimized voxel-based morphometry Psychiatry Clin Neurosci 63 2009 563 568
48. Y.T. Kim, S.W. Lee, D.H. Kwon, J.H. Seo, B.C. Ahn, and J. Lee Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers J Psychiatr Res 43 2009 1166 1170
49. R.L. Cowan, I.K. Lyoo, S.M. Sung, K.H. Ahn, M.J. Kim, and J. Hwang Reduced cortical gray matter density in human MDMA (Ecstasy) users: A voxel-based morphometry study Drug Alcohol Depend 72 2003 225 235
50. K.O. Lim, J.R. Wozniak, B.A. Mueller, D.T. Franc, S.M. Specker, and C.P. Rodriguez Brain macrostructural and microstructural abnormalities in cocaine dependence Drug Alcohol Depend 92 2008 164 172
51. K.L. Medina, T. McQueeny, B.J. Nagel, K.L. Hanson, T.T. Yang, and S.F. Tapert Prefrontal cortex morphometry in abstinent adolescent marijuana users: Subtle gender effects Addict Biol 14 2009 457 468
52. A. Mon, T.C. Durazzo, S. Gazdzinski, and D.J. Meyerhoff The impact of chronic cigarette smoking on recovery from cortical gray matter perfusion deficits in alcohol dependence: Longitudinal arterial spin labeling MRI Alcohol Clin Exp Res 33 2009 1314 1321
53. A.L. Brody, M.A. Mandelkern, M.E. Jarvik, G.S. Lee, E.C. Smith, and J.C. Huang Differences between smokers and nonsmokers in regional gray matter volumes and densities Biol Psychiatry 55 2004 77 84
54. J. Tanabe, J.R. Tregellas, M. Dalwani, L. Thompson, E. Owens, T. Crowley, and M. Banich Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals Biol Psychiatry 65 2009 160 164
55. F.T. Crews, and C.A. Boettiger Impulsivity, frontal lobes and risk for addiction Pharmacol Biochem Behav 93 2009 237 247
56. E.J. Nestler Is there a common molecular pathway for addiction? Nat Neurosci 8 2005 1445 1449
57. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238
58. Y. Yuan, Z. Zhu, J. Shi, Z. Zou, F. Yuan, and Y. Liu Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals Brain Cogn 71 2009 223 228
59. K.D. Ersche, P.C. Fletcher, J.P. Roiser, T.D. Fryer, M. London, T.W. Robbins, and B.J. Sahakian Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers Psychopharmacology 188 2006 364 373
60. J.A. Matochik, D.A. Eldreth, J.L. Cadet, and K.I. Bolla Altered brain tissue composition in heavy marijuana users Drug Alcohol Depend 77 2005 23 30
61. C.J. Morgan, L. Monaghan, and H.V. Curran Beyond the K-hole: A 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug Addiction 99 2004 1450 1461
62. J.R. Tregellas, S. Shatti, J.L. Tanabe, L.F. Martin, L. Gibson, K. Wylie, and D.C. Rojas Gray matter volume differences and the effects of smoking on gray matter in schizophrenia Schizophr Res 97 2007 242 249
63. A.C. Lahti, H.H. Holcomb, D.R. Medoff, and C.A. Tamminga Ketamine activates psychosis and alters limbic blood flow in schizophrenia Neuroreport 6 1995 869 872